Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial

Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov platform as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T16:18:32.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.8%
    Check dated 2026-10-25T15:40:48.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T20:48:40.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T20:34:46.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry (v3.7.0) and removes the older revision (v3.6.6) from the list, reflecting an update to the study record versions.
    Difference
    0.1%
    Check dated 2026-09-20T22:30:05.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new revision, v3.6.6, was added to the study history, replacing the previous v3.6.5 and indicating the record has been updated. This reflects a metadata update to the page rather than a change to the study results.
    Difference
    0.1%
    Check dated 2026-08-30T21:55:18.000Z thumbnail image

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.